Cut-points for PSA doubling time in men with non-metastatic castration-resistant prostate cancer

OBJECTIVES: To examine whether PSADT correlates with metastases, all-cause mortality (ACM), and prostate cancer-specific mortality (PCSM) and identify PSADT cut-points that can be used clinically for risk stratification in men with M0 CRPC. MATERIALS AND METHODS: We collected data on 441 men with M0...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BJU Int
Main Authors: Howard, Lauren E., Moreira, Daniel, De Hoedt, Amanda, Aronson, William J., Kane, Christopher J., Amling, Christopher L., Cooperberg, Matthew R., Terris, Martha K., Freedland, Stephen J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5617753/
https://ncbi.nlm.nih.gov/pubmed/28371163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.13856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados